Nerve Repair & Regeneration Market worth $12.64 billion by 2031
The report "Nerve Repair & Regeneration Market by Product (Neuromodulation devices, Conduit, Wrap, Protector, Grafts), Procedure (Nerve Repair [Epineural, Perineural], Grafting [Allograft, Xenograft]), Application, End User, No. of Devices – Global Forecast to 2031", is projected to grow from USD 8.06 billion in 2026 and to reach USD 12.64 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 9.42% during the forecast period.
Browse 300 market data Tables and 51 Figures spread through 350 Pages and in-depth TOC on "Nerve Repair & Regeneration Market, by Product (Neuromodulation devices, Conduit, Wrap, Protector, Grafts), Procedure (Nerve Repair [Epineural, Perineural], Grafting [Allograft, Xenograft]), Application, End User, No. of Devices – Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/nerve-repair-regeneration-market-883.html
The nerve repair and regeneration market is growing significantly, supported by the increasing number of reconstructive and microsurgical procedures that require effective nerve restoration. Additionally, growing clinical interest in advanced biomaterials, bioengineered scaffolds, and tissue-engineered solutions is creating new opportunities for market expansion. Increasing collaborations between medical device companies, research institutions, and biotechnology firms are accelerating the development and commercialization of innovative nerve repair technologies. Furthermore, improvements in surgical expertise, specialized nerve care infrastructure, and access to advanced peripheral nerve treatment are supporting the adoption of these solutions across healthcare settings.
The neurostimulation and neuromodulation devices segment accounted for the largest share of the nerve repair and regeneration market in 2025.
Based on product, the nerve repair and regeneration market is segmented into neurostimulation and neuromodulation devices and biomaterial-based products. The neurostimulation and neuromodulation devices segment accounted for the largest share of the market in 2025. These devices include spinal cord stimulators, peripheral nerve stimulators, and other neuromodulation systems used to manage nerve-related conditions and support neurological function. Their dominant share reflects the established clinical use of neurostimulation technologies, increasing adoption of minimally invasive treatment approaches, and the growing availability of advanced stimulation systems. In addition, continued technological advancements, expanding clinical applications, and increasing adoption of neuromodulation therapies support sustained demand for these devices and reinforce the segment's leading position throughout the forecast period.
The hospitals and ambulatory surgical centers segment accounted for the largest share of the nerve repair and regeneration market.
The nerve repair and regeneration market, by end user, is segmented into hospitals and ambulatory surgical centers, specialty clinics, and other end users. The hospitals and ambulatory surgical centers segment accounted for the largest market share because these settings perform a high volume of nerve repair, reconstructive, and neuromodulation procedures. Hospitals and ASCs serve as major centers for surgical nerve repair, nerve grafting, and implantation of neurostimulation and neuromodulation devices, driving significant demand for nerve repair and regeneration products. Furthermore, specialized surgical expertise, advanced medical infrastructure, and the growing adoption of minimally invasive procedures are supporting segment growth. The rising need for timely treatment of nerve injuries and neurological conditions continues to strengthen the position of hospitals and ASCs as the leading end-user segment in the nerve repair and regeneration market.
Asia Pacific is expected to register the highest growth rate in the nerve repair and regeneration market during the forecast period.
The nerve repair and regeneration market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is projected to grow at the highest CAGR from 2026 to 2031. China, Japan, and India are the region's primary growth markets. Japan's aging population and increasing prevalence of age-related neurological conditions are creating greater demand for advanced nerve treatment solutions. China's expanding medical device industry and increasing availability of specialized neurological care are supporting the development and adoption of nerve repair technologies. Meanwhile, India's growing number of surgical centers, improving access to specialized peripheral nerve care, and increasing availability of advanced medical devices are creating new opportunities for market growth. North America held the largest regional share in 2025, supported by specialized neurological centers, high adoption of sophisticated surgical interventions, favorable reimbursement conditions, and strong clinical expertise in peripheral nerve and neuromodulation procedures.
The major market players covered in the report include Medtronic plc (Ireland), Boston Scientific Corporation (US), Axogen Corporation (US), Baxter (US), Integra LifeSciences Corporation (US), NeuroPace, Inc. (US), Bioventus Inc. (US), Abbott Laboratories (US), LivaNova PLC (UK), and Neuronetics, Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Nerve Repair & Regeneration Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
